Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Combivent® UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) in a Double-Blind Efficacy and Safety Study in Asthmatic Children With Severe Acute Exacerbation

NCT00273962 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00273962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00273962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Combivent® UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) in a Double-Blind Efficacy and Safety Study in Asthmatic Children With Severe Acute Exacerbation
Lead sponsor
Boehringer Ingelheim
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2002
Completion date
November 30, 2003
Enrollment
500 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

asthma